October 23, 2007 - PLC Systems Inc. introduced at TCT 2007 the RenalGuard System, an investigational system and therapy ...
October 23, 2007 - Hologic Inc.
October 23, 2007 – Patients who received the CYPHER Sirolimus-eluting coronary stent had a lower risk of stent ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
October 22, 2007 – A time-motion study conducted at Providence Heart Institute in Columbia, SC, spanning approximately ...
October 22, 2007 – At TCT 2007, ProSolv CardioVascular, a FUJIFILM company, (ProSolv) demonstrated its advanced ...
October 22, 2007 - GE Healthcare highlighted the advantages of its digital flat panel Biplane imaging systems, the ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
October 22, 2007 – Stent thrombosis rates through one year were low for both the TAXUS Express2 Paclitaxel-Eluting ...
October 22, 2007 – Philips highlighted the integration of Volcano’s IVUS into its new Xper system and TrueView’s ability ...
October 22, 2007 - Implantation of the CYPHER Sirolimus-eluting Coronary Stent by Cordis Corp. used to treat completely ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
The HI VISION 5500 fully digital ultrasound system reportedly delivers the latest generation of signal processing ...
October 18, 2007 - Vascular Solution Inc. spotlights its Guardian hemostasis valve and Gopher Support Catheter at TCT ...
October 18, 2007 - Boston Scientific Corp. today announced it will restructure or sell several business units to reduce operating expenses by 13 percent in 2008 in a move designed to enhance short- and long-term shareholder value.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
October 18, 2007 - This year at TCT ProSolv CardioVascular, a FUJIFILM company and leading provider of enterprise-level ...
Ever since the BASKET-LATE study came out suggesting an increase in the rate of death and myocardial infarction in ...
October 18, 2007 - Guerbet will feature at TCT 2007 its x-ray contrast agent, Oxilan (ioxilan) injection, a contrast ...
October 22, 2007
